Life ScienceCompany
AYUMI Pharmaceutical Ownership
Who owns AYUMI Pharmaceutical?
AYUMI Pharmaceutical is owned by The Blackstone Group. It was acquired on March 15, 2019.
Is AYUMI Pharmaceutical PE-backed?
Yes. AYUMI Pharmaceutical is owned by private equity investor The Blackstone Group.
Was AYUMI Pharmaceutical formerly PE-backed?
Yes. AYUMI Pharmaceutical was formerly owned by 1 private investor.
AYUMI Pharmaceutical Business Overview
Where is AYUMI Pharmaceutical headquartered?
AYUMI Pharmaceutical is headquartered in Tokyo, Japan.
What sector is AYUMI Pharmaceutical in?
AYUMI Pharmaceutical is a life science company.
When was AYUMI Pharmaceutical founded?
AYUMI Pharmaceutical was founded in 2015.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.